Registered Nurse in Chanhassen, MN Accepting Medicare
6 Registered Nurse nurses found. Showing 1 - 6
 Mrs. Cindy Lou Egelston, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2018 Stone Creek Dr, Chanhassen, MN 55317 Phone: 952-470-6005 |
Sondra Windus, Registered Nurse Medicare: Medicare Enrolled Practice Location: 300 Lake Dr E, Chanhassen, MN 55317 Phone: 952-993-4300 Fax: 952-993-4320 |
Ms. Mary Margaret Bateman, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1030 Saddlebrook Trl, Chanhassen, MN 55317 Phone: 952-474-0271 |
Laura Olsen, RN Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 901 Vineland Ct, Chanhassen, MN 55317 Phone: 612-236-3060 |
Joy L Chall, Registered Nurse - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 300 Lake Dr E, Epark Nicollet Clinic - Chanhassen, Chanhassen, MN 55317 Phone: 952-993-4300 |
Sydney Gunderson, Registered Nurse Medicare: Medicare Enrolled Practice Location: 7907 Powers Blvd, Chanhassen, MN 55317 Phone: 952-934-0570 |
News Archive
Nanostructures around brain cells may have role in central nervous system function
An accumulation of a protein called amyloid-beta into large insoluble deposits called plaques is known to cause Alzheimer's disease. One aspect of this illness that has not received much attention is which role the structure of the brain environment plays.
Orphan Europe files NDA with FDA for Carbaglu (carglumic acid)
Recordati announced the submission to the U.S. FDA by Orphan Europe (a Recordati group company) of an Original New Drug Application (NDA) for Carbaglu (carglumic acid).
Mycobacterium tuberculosis can grow in surface-level bacteria clusters known as biofilms
University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in Molecular Microbiology.
Scientists discover Deep Brain Stimulation as potential treatment for early Alzheimer's
In a world first, Dr. Andres M. Lozano and his team at Toronto Western Hospital has shown using Deep Brain Stimulation (DBS) on patients with early signs of Alzheimer's disease is safe and may help improve memory. The phase one safety trial of six Ontario patients took place from 2005 to 2008. All patients left hospital within 2 to 3 days of surgery, and continue to participate in regular follow-up cognitive assessments.
Jobs with greater risk for COVID-19 exposure have high number of Black or Hispanic workers
Black and Hispanic people experience a higher risk for COVID-19 and severe illness, influenced by factors such as discrimination, housing, and healthcare access and utilization.
› Verified 4 days ago
Nurse Practitioner
Registered Nurse
Physician Assistant
Clinical Nurse Specialist